FDA: Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials; Public Meeting
Jan 8, 2021The FDA will be holding a public meeting to gather input on the scientific and ethical issues that surround the inclusion of pregnant women in clinical trials for drug development. The meeting will be held on 2/2/21 from 10am-2pm and 2/3/21 from 10am-1pm. For more information, click here.